Abstract
Two patients with refractory symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH) were treated by continuous intra-arterial nimodipine infusion via a catheter placed in the internal carotid artery or vertebral artery for 3 and 12 days, respectively. Recovery of the neurological deficits, normalization of MR perfusion, a decrease in the elevated mean flow velocity measured by transcranial duplex sonography, and angiographic recanalization were observed. Continuous intra-arterial nimodipine might be a treatment option in severe refractory vasospasm following SAH.
Similar content being viewed by others
References
Weir B, MacDonald L (1993) Cerebral vasospasm. Clin Neurosurg 40:40–45
Rinkel G, Feigin V, Algra A, Bergh W, Vermeulen M, Gijn J (2005) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 25:CD000277
Meyer FB (1990) Calcium antagonists and vasospasm. Neurosurg Clin N Am 1:367–376
Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J (1999) Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 44:975–979
Terry A, Zipfel G, Milner E et al (2006) Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus 21:E14
Numaguchi Y, Zoarski GH, Clouston JE et al (1997) Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage. Neuroradiology 39:751–759
Liu JK, Tenner MS, Gottfried ON et al (2004) Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. J Neurosurg 100:414–421
Biondi A, Ricciardi GK, Puybasset L et al (2004) Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. Am J Neuroradiol 25:1067–1076
Hui C, Lau KP (2005) Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clin Radiol 60:1030–1036
Badjatia N, Topcuoglu MA, Pryor JC et al (2004) Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol 25:819–826
Feng L, Fitzsimmons BF, Young WL et al (2002) Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. Am J Neuroradiol 23:1284 –1290
Böker DK, Solymosi L, Wassmann H (1985) Immediate postangiographic intraarterial treatment of cerebral vasospasm after subarachnoid hemorrhage with nimodipine: report on 3 cases. Neurochirurgia 28:118–120
Grotenhuis JA, Bettag W, Fiebach BJ, Dabir K (1984) Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH: a preliminary report. J Neurosurg 61:231–240
Grotenhuis JA, Bettag W (1986) Prevention of symptomatic vasospasm after SAH by constant venous infusion of nimodipine. Neurol Res 8:243–249
Zygmunt SC, Delgado-Zygmunt TJ (1995) The haemodynamic effect of transcranial Doppler-guided high-dose nimodipine treatment in established vasospasm after subarachnoid hemorrhage. Acta Neurochir 135:179–185
Suzuki S, Ito O, Sayama T, Yamaguchi S, Goto K, Sasaki T (2006) Intraarterial injection of colforsin daropate hydrochloride for the treatment of vasospasm after aneurysmal subarachnoid hemorrhage: preliminary report of two cases. Neuroradiology 48:50–53
Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN (2000) Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: part II. Clinical aspects and recommendations. Neurosurgery 46:1360–1375
Barth M, Capelle HH, Weidauer S et al (2007) Effect of nicardipine prolonged-release implants on cerebral vasospasm and outcome after severe aneurysmal subarachnoid hemorrhage. A prospective, randomized, double-blind phase IIa clinical study. Stroke 38:330–336
Vajkoczy P, Meyer B, Weidauer S et al (2005) Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter Phase IIa study. J Neurosurg 103:9–17
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mayer, T.E., Dichgans, M., Straube, A. et al. Continuous Intra-Arterial Nimodipine for the Treatment of Cerebral Vasospasm. Cardiovasc Intervent Radiol 31, 1200–1204 (2008). https://doi.org/10.1007/s00270-008-9346-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-008-9346-0